(2022) recently demonstrated that deficiency of beclin-1, the key molecule of autophagy, promoted renal fibrosis and consequently delayed recovery following renal injury
Jiangsu Hengrui Pharmaceuticals licenses portfolio of GLP-1-based drug candidates Deal announced: 17 May 2024 Potential deal value: $6,035 million Deal overview: Jiangsu Hengrui Pharmaceuticals, a company headquartered in Lianyungang, China, licensed three GLP-1-based investigational drug candidates to a newly founded company originally known as Hercules CM NewCo, backed by investors including Atlas Venture, Bain Capital and RTW
For others, it can take longer, especially if symptoms have been present for months or if there are multiple contributing factors (iron, vitamin D, thyroid issues, sleep, stress, etc.)
Proshkina E, Plyusnin S, Babak T, Lashmanova E, Maganova F, Koval L, et al